Related Experiment Video
Updated: Jun 2, 2026

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
The efficacy of oral midazolam for decreasing anxiety in children undergoing voiding cystourethrogram: a randomized,
Genoa G Ferguson1, Cathy Chen, Yan Yan
1Division of Urology, Washington University School of Medicine, St. Louis, Missouri, USA.
Insights
Oral midazolam did not significantly reduce anxiety in children undergoing voiding cystourethrogram (VCUG). The study found no significant benefits for child anxiety, parent anxiety, or post-procedure behavior.
Area of Science:
- Pediatric Radiology
- Pediatric Anesthesiology
- Child Psychology
Background:
- Voiding cystourethrogram (VCUG) is an essential diagnostic imaging procedure for pediatric urinary tract infections.
- The invasive nature of VCUG can induce significant anxiety in children and their parents.
- Effective anxiety management strategies are crucial for improving the patient experience during VCUG.
Purpose of the Study:
- To evaluate the efficacy of oral midazolam in reducing pre-procedural anxiety in children undergoing VCUG.
- To assess the impact of midazolam on parent anxiety levels during the procedure.
- To investigate the effect of midazolam on post-procedural behavioral outcomes and healthcare provider perceptions.
Main Methods:
- A double-blind, randomized controlled trial involving 44 children undergoing VCUG.
- Children were randomized to receive either oral midazolam or a placebo prior to the procedure.
- Anxiety was measured using the Modified Yale Preoperative Anxiety Scale (children) and State-Trait Anxiety Inventory (parents). Post-procedure behavior was assessed using the Post Hospitalization Behavior Questionnaire.
Main Results:
- No statistically significant difference in anxiety scores was observed between the midazolam and placebo groups for children.
- Parental anxiety levels during the VCUG were also not significantly different between the two groups.
- Radiology staff perceived no reliable benefit of midazolam, and no adverse behavioral outcomes were noted in children up to six months post-procedure.
Conclusions:
- Oral midazolam does not appear to significantly alleviate anxiety in children undergoing voiding cystourethrogram.
- The medication showed no significant benefit in reducing parental anxiety or improving post-procedural behavior in children.
- Healthcare provider perceptions suggest midazolam offers no reliable advantage for anxiety reduction during VCUG procedures.
Purpose:
Voiding cystourethrogram is an invasive test that evokes anxiety. Our primary aim was to determine whether midazolam is beneficial in decreasing anxiety in children who undergo voiding cystourethrogram. Secondary aims were an examination of parent anxiety, health care professional perceptions and post-procedure behavioral outcomes in children after voiding cystourethrogram.
Materials And Methods:
A total of 44 children were randomized to placebo or oral midazolam before voiding cystourethrogram in double-blind fashion. The Modified Yale Preoperative Anxiety Scale was used to evaluate child behavior before and during voiding cystourethrogram, and the Post Hospitalization Behavior Questionnaire was used to investigate any short-term and intermediate-term behavioral outcomes. The State-Trait Anxiety Inventory was used to evaluate parent personal anxiety during voiding cystourethrogram. A separate questionnaire was administered to radiology staff. Statistical analysis included the 2-sample t and Fisher exact tests.
Results:
There was no difference in Modified Yale Preoperative Anxiety Scale scores in children randomized to midazolam or placebo. There was also no significant difference in parent anxiety. Radiology care providers identified no reliable benefit when blinded to sedation vs placebo. We did not note any post-procedural behavior issues after voiding cystourethrogram at up to 6 months of followup.
Conclusions:
Midazolam may not significantly help with child or parent anxiety during voiding cystourethrogram. No reliable benefit was noted according to radiology health care provider perception and there was no significant post-procedural behavior benefit. Midazolam may not provide a significant benefit in decreasing anxiety during voiding cystourethrogram.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Anxiolytic Drugs: Benzodiazepines and Buspirone
Urodynamic Studies: Uroflowmetry
Urologic Endoscopic Procedure: Cystoscopic Examination
Drug Delivery: Enteral Route
Drugs in...